Digest

This Curb Siders podcast episode features Dr. Brad Beeler, discussing common benign hematology issues. Three case studies are presented: a young African-American woman with asymptomatic neutropenia (likely DANK), a 24-year-old male with recurrent nosebleeds, and a 38-year-old Vietnamese woman with chronic iron deficiency anemia despite normal ferritin (suspected thalassemia). The discussion emphasizes the importance of appropriate workup and avoiding unnecessary testing in asymptomatic neutropenia. For bleeding disorders, a bleeding assessment tool is highlighted to guide referral decisions and initial testing (CBC, PT/PTT, INR). In cases of chronic iron deficiency anemia, thalassemia is considered in the differential diagnosis, necessitating hemoglobin electrophoresis and blood smear review. The podcast stresses avoiding systemic bias in diagnosis, utilizing assessment tools, understanding elevated PTT, and the collaborative role of primary care in managing thalassemia.

Outlines

00:00:59

Introduction: Benign Hematology Overview & Case Previews

Introduction to the podcast and guest, Dr. Beeler. Overview of the episode's focus on neutropenia, bleeding disorders, and thalassemia, with brief case previews.

00:07:12

Case Study 1: Asymptomatic Neutropenia (DANK)

Discussion of a case of asymptomatic neutropenia in a young African-American woman. Focus on appropriate workup for Duffy Null Associated Neutropenia (DANK), emphasizing reassurance and avoiding unnecessary testing in asymptomatic patients with stable counts.

00:19:42

Case Study 2: Evaluating Recurrent Bleeding

A 24-year-old male presents with recurrent nosebleeds and easy gum bleeding. Focus on using a bleeding assessment tool to determine the need for hematology referral and appropriate initial testing (CBC, PT/PTT, INR).

00:53:42

Case Study 3: Chronic Anemia & Thalassemia

A 38-year-old Vietnamese woman with chronic iron deficiency anemia despite normal ferritin. Discussion explores the differential diagnosis, including thalassemia, and the importance of hemoglobin electrophoresis and blood smear review.

01:14:30

Key Diagnostic & Management Considerations

Summary of key learning points from the case discussions, emphasizing accurate diagnosis and appropriate patient management strategies across the presented cases.

01:15:11

Key Takeaways & Collaborative Care

Recap of key takeaways, emphasizing avoiding systemic bias in neutropenia diagnosis, using bleeding assessment tools, understanding elevated PTT, and the importance of primary care's role in managing thalassemia patients.

Keywords

Q&A

• What is the appropriate approach to a patient with an asymptomatic neutrophil count of 1100 and an African American background?

  Assess for symptoms. If asymptomatic and with a stable history, reassurance is key. Genetic testing is generally unnecessary unless there are concerning symptoms.

• How should primary care physicians approach a patient with suspected bleeding disorder?

  Utilize a bleeding assessment tool. Atypical bleeders require hematology referral. Initial testing should include CBC, PT/PTT, INR, and potentially an iron panel.

• A patient presents with chronic microcytic anemia, normal ferritin, and elevated RBC count. What should be considered?

  This suggests thalassemia. Hemoglobin electrophoresis should be performed. A blood smear can reveal characteristic features.

• How can clinicians differentiate between benign and pathologic neutropenia?

  Consider the patient's symptoms, absolute neutrophil count (ANC), and underlying conditions. Asymptomatic patients with an ANC above 1000 often have benign neutropenia.

• What is the importance of bleeding assessment tools in managing bleeding patients?

  These tools help quantify bleeding risk and guide management decisions. They help determine which patients need hematology evaluation.

• What is the role of primary care physicians in managing patients with thalassemia?

  Primary care physicians play a vital role in screening for and managing complications associated with thalassemia. Collaboration with hematologists is essential.

Show Notes